Jim Hagstrom, Ph.D., received his Ph.D. in molecular biology from Mayo Clinic Graduate School of Biomedical Sciences in 1990. He completed his postdoctoral fellowship at the University of California, San Diego, studying the molecular basis of neuronal cell differentiation using the PC12 cell line model.
After completing his training, Dr. Hagstrom was a research associate at the University of Wisconsin-Madison, where his research focused on understanding the mechanism of cellular uptake of nucleic acids using cationic lipids, polymers and proteins.
To further develop these technologies, Dr. Hagstrom co-founded Mirus Bio in 1995, which has become a world leader in nonviral nucleic acid delivery (pDNA and siRNA) into cells in culture (in vitro) and in the body (in vivo). The corporation was later acquired by Roche and split into two entities. Dr. Hagstrom was a vice president at Roche Madison from 2008 to 2010. Since 2010, he has served as president of Mirus Bio LLC.
Since founding Mirus, Dr. Hagstrom has been the principal investigator on numerous grants and an author on many scientific publications and patents. To date, he is an inventor on nearly 150 U.S. patents (61 issued and 88 pending) and many international patents.
Jan. 09, 2015